Cargando…
5-Arylaminouracil Derivatives as Potential Dual-Action Agents
Several 5-aminouracil derivatives that have previously been shown to inhibit Mycobacterium tuberculosis growth at concentrations of 5–40 μg/mL are demonstrated to act also as noncompetitive non-nucleoside inhibitors of HIV-1 reverse transcriptase without causing toxicity in vitro (MT-4 cells) and ex...
Autores principales: | Matyugina, E. S., Novikov, M. S., Babkov, D. A., Valuev-Elliston, V. T., Vanpouille, C., Zicari, S., Corona, A., Tramontano, E., Margolis, L. B., Khandazhinskaya, A. L., Kochetkov, S. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610172/ https://www.ncbi.nlm.nih.gov/pubmed/26483967 |
Ejemplares similares
-
New Derivatives of 5-Substituted Uracils: Potential Agents with a Wide Spectrum of Biological Activity
por: Kezin, Vasily A., et al.
Publicado: (2022) -
New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2
por: Maslova, A. A., et al.
Publicado: (2022) -
Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties
por: Maslova, Anna A., et al.
Publicado: (2020) -
Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2
por: Matyugina, E. S., et al.
Publicado: (2021) -
N(1),N(3)-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase
por: Novikov, Mikhail S., et al.
Publicado: (2013)